Therapeutic Pipeline Tracker
Explore nonprofit patient-led drug development programs across all stages.
Making Patient-Led Therapeutic Development Visible and Investable
Across ultra-rare diseases, patient organizations are advancing real therapeutic development programs, from natural history studies to preclinical and clinical assets. Yet this work is often fragmented and invisible beyond individual diseases.
The Patient-Led Pipeline Tracker brings these efforts together in a single, living view to show that patient-led therapeutic development is not anecdotal. It is a growing, disciplined, and investable area of activity.
By aggregating programs across diseases and stages, the tracker:
- Increases visibility for patient-led programs
- Signals readiness to funders, investors, and partners
- Reduces friction for collaboration and follow-on capital
For patient groups, the tracker offers visibility and connection.
For funders and investors, it provides a transparent view into an emerging pipeline of ultra-rare programs.
This is infrastructure for a new category of medicine, built by patients and designed to scale.
Disclaimer: All programs listed in the Buffalo Patient-Powered Pipeline Tracker are self-reported by the submitting organizations. Buffalo has not independently verified, validated, or conducted due diligence on the scientific, clinical, or commercial claims associated with these programs. Buffalo does not endorse individual programs. Content is provided to increase access, awareness and transparency.